May 11th 2021
Experts discuss best practices for treating patients with HER2+ breast cancer and suspected or actual brain metastases, as well as considerations for treatment sequencing and the identification and management of interstitial lung disease.
April 8th 2021
Experts in urology and nuclear medicine discuss the identification and management of biochemical recurrence in prostate cancer using 2 patient cases as examples.
February 23rd 2021
Recommendations for managing 2 patient cases specific to HER2-positive metastatic breast cancer and optimizing therapy for specific patient populations within the HER2-positive space based on emerging treatments and changes to standards of care.